NCT01312935View on ClinicalTrials.gov

Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2012

Conditions
Percutaneous Coronary InterventionCoronary Artery Disease (CAD)Angioplasty
Interventions
DRUG

PMX-60056

investigational drug

Trial Locations (3)

Unknown

South Bend

Detroit

Rapid City

Sponsors

Lead Sponsor

PolyMedix, Inc.
All Listed Sponsors
lead

PolyMedix, Inc.

INDUSTRY